|1.||Lee, Ethan: 5 articles (12/2015 - 01/2010)|
|2.||Hang, Brian I: 3 articles (01/2014 - 11/2010)|
|3.||Orton, Darren: 3 articles (01/2014 - 11/2010)|
|4.||Esumi, Hiroyasu: 3 articles (08/2012 - 08/2004)|
|5.||Saraswati, Sarika: 2 articles (12/2015 - 01/2010)|
|6.||Young, Pampee P: 2 articles (12/2015 - 01/2010)|
|7.||Jones, Jeremy O: 2 articles (03/2014 - 04/2009)|
|8.||Kita, Kiyoshi: 2 articles (08/2012 - 07/2010)|
|9.||Tomitsuka, Eriko: 2 articles (08/2012 - 07/2010)|
|10.||Harada, Yasuo: 2 articles (06/2012 - 01/2012)|
01/01/2013 - "This study supports a novel cancer therapeutic strategy based on targeting autophagy addiction and implicates using pyrvinium as an autophagy inhibitor in combination with chemotherapeutic agents to improve their therapeutic efficacy."
03/21/2014 - "Our results suggest that the noncompetitive AR inhibitor pyrvinium has significant potential to treat CRPC, including cancers driven by ligand-independent AR signaling. "
01/01/2013 - "Pyrvinium targets autophagy addiction to promote cancer cell death."
01/01/2012 - "Reprofiling a classical anthelmintic, pyrvinium pamoate, as an anti-cancer drug targeting mitochondrial respiration."
07/01/2010 - "Pyrvinium pamoate, an anthelmintic drug, has an anticancer effect within tumor-mimicking microenvironments. "
01/01/1963 - "[FIRST RESULTS WITH THE USE OF THE PARKE-DAVIS PREPARATION "MOLEVAC"--A DRUG EFFECTIVE AGAINST ENTEROBIASIS. "
01/01/2014 - "Considering its well-documented safe use for treating enterobiasis in humans, our findings suggest that Pyrvinium could be repurposed for the clinical treatment of APC-associated polyposes. "
09/01/1978 - "[Confirming the possibility of long-term elimination of enterobiasis in a pediatric collective through repeated mass therapy using Pyrvinium Spofa]."
01/01/1977 - "[Treatment of enterobiasis in children with pyrvinium pamoate]."
05/01/1972 - "[Therapy of enterobiasis with Pyrvinium Spofa suspension]."
09/01/2008 - "Efficacy of pyrvinium pamoate against Cryptosporidium parvum infection in vitro and in a neonatal mouse model."
09/01/2008 - "We observed a >90% reduction in infection intensity in pyrvinium-treated mice relative to that in untreated controls, along with a substantial reduction in tissue pathology. "
08/10/1964 - "TREATMENT OF PINWORM INFECTIONS WITH REDUCED SINGLE DOSE OF PYRVINIUM PAMOATE."
09/01/2008 - "Beginning 3 days after infection, pyrvinium at 5 or 12.5 mg/kg of body weight/day was administered to the treatment group mice for 4 or 6 consecutive days. "
02/01/1962 - "Pyrvinium pamoate in the treatment of pinworm infection (enterobiasis) in the home."
01/01/2010 - "To evaluate its effect in myocardial repair, we induced a myocardial infarction (MI) by coronary artery ligation and administered a single intramyocardial dose of pyrvinium. "
01/01/2013 - "An anthelmintic drug, pyrvinium pamoate, thwarts fibrosis and ameliorates myocardial contractile dysfunction in a mouse model of myocardial infarction."
01/01/2013 - "Furthermore, Pyrvinium pamoate reduces scar formation and improves cardiac contractility in a mouse model of myocardial infarction. "
|1.||Deoxyglucose (2 Deoxy D glucose)
|6.||Pyrantel Pamoate (Pyrantel Embonate)
|10.||Casein Kinases (Casein Kinase)
|2.||Heterologous Transplantation (Xenotransplantation)